These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1826840)

  • 21. Effects of pretreatment with the retinoid N-(4-hydroxyphenyl)-all-trans-retinamide and phenobarbital on the disposition and metabolism of N-(4-hydroxyphenyl)-all-trans-retinamide in mice.
    Hultin TA; McCormick DL; May CM; Moon RC
    Drug Metab Dispos; 1988; 16(6):783-8. PubMed ID: 2907453
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of the fenretinide metabolite 4-oxo-fenretinide present in human plasma and formed in human ovarian carcinoma cells through induction of cytochrome P450 26A1.
    Villani MG; Appierto V; Cavadini E; Valsecchi M; Sonnino S; Curley RW; Formelli F
    Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6265-75. PubMed ID: 15448016
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 4-HPR Is an Endoplasmic Reticulum Stress Aggravator and Sensitizes Breast Cancer Cells Resistant to TRAIL/Apo2L.
    Anding AL; Jones JD; Newton MA; Curley RW; Clagett-Dame M
    Anticancer Res; 2018 Aug; 38(8):4403-4416. PubMed ID: 30061204
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liquid chromatography method for quantifying N-(4-hydroxyphenyl)retinamide and N-(4-methoxyphenyl)retinamide in tissues.
    Vratilova J; Frgala T; Maurer BJ; Patrick Reynolds C
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Sep; 808(2):125-30. PubMed ID: 15261805
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of mammary tumor growth by a novel nontoxic retinoid: chemotherapeutic evaluation of a C-linked analog of 4-HPR-glucuronide.
    Alshafie GA; Walker JR; Curley RW; Clagett-Dame M; Highland MA; Nieves NJ; Stonerock LA; Abou-Issa H
    Anticancer Res; 2005; 25(3c):2391-8. PubMed ID: 16082771
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential effects of N-(4-hydroxyphenyl)retinamide and retinoic acid on neuroblastoma cells: apoptosis versus differentiation.
    Ponzoni M; Bocca P; Chiesa V; Decensi A; Pistoia V; Raffaghello L; Rozzo C; Montaldo PG
    Cancer Res; 1995 Feb; 55(4):853-61. PubMed ID: 7850799
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fenretinide-induced apoptosis of human head and neck squamous carcinoma cell lines.
    Scher RL; Saito W; Dodge RK; Richtsmeier WJ; Fine RL
    Otolaryngol Head Neck Surg; 1998 Apr; 118(4):464-71. PubMed ID: 9560096
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of aberrant proliferation and induction of apoptosis in HER-2/neu oncogene transformed human mammary epithelial cells by N-(4-hydroxyphenyl)retinamide.
    Jinno H; Steiner MG; Mehta RG; Osborne MP; Telang NT
    Carcinogenesis; 1999 Feb; 20(2):229-36. PubMed ID: 10069458
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanism of growth inhibition of mammary carcinomas by glucarate and the glucarate: retinoid combination.
    Webb TE; Abou-Issa H; Stromberg PC; Curley RC; Nguyen MH
    Anticancer Res; 1993; 13(6A):2095-9. PubMed ID: 8297119
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activity of D-glucarate analogues: synergistic antiproliferative effects with retinoid in cultured human mammary tumor cells appear to specifically require the D-glucarate structure.
    Curley RW; Humphries KA; Koolemans-Beynan A; Abou-Issa H; Webb TE
    Life Sci; 1994; 54(18):1299-303. PubMed ID: 8190001
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolism of N-[4-hydroxyphenyl]retinamide (4-HPR) to N-[4-methoxyphenyl]retinamide (4-MPR) may serve as a biomarker for its efficacy against human breast cancer and melanoma cells.
    Mehta RR; Hawthorne ME; Graves JM; Mehta RG
    Eur J Cancer; 1998 May; 34(6):902-7. PubMed ID: 9797705
    [TBL] [Abstract][Full Text] [Related]  

  • 32. N-(4-hydroxyphenyl)retinamide (Fenretinide) in combination with retinoic acid enhances differentiation and retinoylation of proteins.
    Takahashi N; Sausville EA; Breitman TR
    Clin Cancer Res; 1995 Jun; 1(6):637-42. PubMed ID: 9816026
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of N-(4-hydroxyphenyl)retinamide on murine mammary tumor cells in culture.
    Bunk MJ; Telang NT; Higgins PJ; Traganos F; Sarkar NH
    Nutr Cancer; 1985; 7(1-2):105-15. PubMed ID: 2999720
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synergistic effects of the fenretinide (4-HPR) and anti-CD20 monoclonal antibodies on apoptosis induction of malignant human B cells.
    Shan D; Gopal AK; Press OW
    Clin Cancer Res; 2001 Aug; 7(8):2490-5. PubMed ID: 11489831
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemoprevention of skin carcinogenesis by phenylretinamides: retinoid receptor-independent tumor suppression.
    Xu H; Cheepala S; McCauley E; Coombes K; Xiao L; Fischer SM; Clifford JL
    Clin Cancer Res; 2006 Feb; 12(3 Pt 1):969-79. PubMed ID: 16467112
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A retinoic acid resistant HL-60 cell clone sensitive to N-(4-hydroxyphenyl) retinamide-mediated clonal growth inhibition.
    Brigati C; Ferrari N; Megna M; Roncella S; Cutrona G; Tosetti F; Vidali G
    Leuk Lymphoma; 1995 Mar; 17(1-2):175-80. PubMed ID: 7773156
    [TBL] [Abstract][Full Text] [Related]  

  • 37. N-(4-hydroxyphenyl) retinamide is cytotoxic to melanoma cells in vitro through induction of programmed cell death.
    Montaldo PG; Pagnan G; Pastorino F; Chiesa V; Raffaghello L; Kirchmeier M; Allen TM; Ponzoni M
    Int J Cancer; 1999 Apr; 81(2):262-7. PubMed ID: 10188729
    [TBL] [Abstract][Full Text] [Related]  

  • 38. pRb and Cdk regulation by N-(4-hydroxyphenyl)retinamide.
    Panigone S; Debernardi S; Taya Y; Fontanella E; Airoldi R; Delia D
    Oncogene; 2000 Aug; 19(35):4035-41. PubMed ID: 10962560
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolism of the chemopreventive retinoid N-(4-hydroxyphenyl)retinamide by mammary gland in organ culture.
    Mehta RG; Hultin TA; Moon RC
    Biochem J; 1988 Dec; 256(2):579-84. PubMed ID: 2851995
    [TBL] [Abstract][Full Text] [Related]  

  • 40. N-(4-Hydroxyphenyl)retinamide and nitric oxide pro-drugs exhibit apoptotic and anti-invasive effects against bone metastatic breast cancer cells.
    Simeone AM; Colella S; Krahe R; Johnson MM; Mora E; Tari AM
    Carcinogenesis; 2006 Mar; 27(3):568-77. PubMed ID: 16199439
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.